Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Feb 1, 2021 | Post-IPO Equity | $220.35M | 1 | Gilead Sciences | — | Detail |
May 28, 2020 | Post-IPO Equity | $200M | 1 | Gilead Sciences | — | Detail |
Mar 14, 2018 | IPO | $120M | — | — | — | Detail |
Nov 13, 2017 | Series C | $107M | 14 | GV | — | Detail |
Sep 1, 2016 | Series B | $70M | 10 | — | — | Detail |
May 1, 2015 | Series A | $49.70M | 2 | — | — | Detail |